Olanzapine attenuates the reinforcing effects of cocaine

European Journal of Pharmacology
W M Meil, M D Schechter

Abstract

The possibility that the atypical neuroleptic olanzapine can antagonize the ability of cocaine to produce both conditioned place preference and self-administration in rats was investigated. Pre-treatment with olanzapine (3.0, 4.5 mg/kg, but not 1.5 mg/kg) significantly attenuated conditioned place preference produced by cocaine (10 mg/kg). However, the higher dose of olanzapine administered alone resulted in conditioned place aversion. Pre-treatment with olanzapine also produced a dose-dependent decrease in cocaine self-administration (0.33 mg/infusion) under a fixed-ratio 2 schedule of reinforcement. Olanzapine produced a similar dose-responsive attenuation in operant responding for food (fixed-ratio 10) suggesting that olanzapine produces a nonspecific decrease in operant behavior. Pre-treatment with 4.5 mg/kg olanzapine significantly attenuated cocaine-induced hyperactivity, whereas lower olanzapine doses had little effect upon cocaine-induced hyperactivity. These results suggest that pre-treatment with olanzapine is capable of blocking the reinforcing effects of cocaine and illustrates the value of using multiple tests of reinforcement when evaluating the pharmacological effects of newer psychotherapeutic agents.

References

Jun 1, 1977·Pharmacology, Biochemistry, and Behavior·D C RobertsH C Fibiger
Jul 1, 1992·Pharmacology, Biochemistry, and Behavior·E A LohD C Roberts
Aug 1, 1991·Pharmacology, Biochemistry, and Behavior·D R BrittonD Kerkman
May 1, 1991·Pharmacology, Biochemistry, and Behavior·R Peltier, S Schenk
Jul 1, 1991·Pharmacology, Biochemistry, and Behavior·W A Corrigall, K M Coen
Jan 1, 1990·Neuroscience and Biobehavioral Reviews·J BruhwylerM Mercier
Feb 1, 1989·Psychiatry Research·M A ShererJ H Jaffe
Mar 1, 1989·Pharmacology, Biochemistry, and Behavior·W L Woolverton, R M Virus
Apr 1, 1989·Archives of General Psychiatry·F H GawinB Humblestone
Sep 1, 1982·Pharmacology, Biochemistry, and Behavior·M W Emmett-OglesbyD E Arnoult
May 1, 1980·Pharmacology, Biochemistry, and Behavior·D C RobertsH C Fibiger
Jan 1, 1993·Psychopharmacology·R Peltier, S Schenk
Jan 1, 1994·Life Sciences·T A Kosten, E J Nestler
Jan 1, 1994·Neuroscience and Biobehavioral Reviews·J M Witkin
Jan 1, 1993·Neuroscience and Biobehavioral Reviews·M D Schechter, D J Calcagnetti
Jun 1, 1996·Pharmacology, Biochemistry, and Behavior·B Geter-Douglass, A L Riley
Feb 1, 1996·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·F P BymasterD T Wong

❮ Previous
Next ❯

Citations

Sep 6, 2002·Pharmacology, Biochemistry, and Behavior·David J RademacherRhea E Steinpreis
Oct 9, 1999·Pharmacology, Biochemistry, and Behavior·N van CampenhoutT F Meert
Dec 22, 1998·Brain Research. Brain Research Reviews·K C Berridge, T E Robinson
Jan 29, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Jordan A MechanicFrank A Holloway
May 22, 2003·Drug and Alcohol Dependence·Kyle M KampmanCharles P O'Brien
Jan 5, 2002·Journal of Substance Abuse Treatment·K H LittrellC G Johnson
May 4, 2000·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·V M SimónM A Aguilar
Jul 30, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Leonard L HowellHeather L Kimmel
Dec 28, 2007·Journal of Psychoactive Drugs·Roy R Reeves
Mar 1, 2011·Neuropharmacology·Danuta Marona-LewickaDavid E Nichols
Aug 7, 2002·The Journal of Pharmacy and Pharmacology·P N DeslandesR D E Sewell
Feb 16, 2015·Drug and Alcohol Dependence·Andre TappAndrew J Saxon
Oct 10, 2013·The International Journal of Neuropsychopharmacology·E M van der ZwaalR A H Adan
Sep 6, 2008·Progress in Brain Research·Marcy J Bubar, Kathryn A Cunningham
Mar 25, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·John GrabowskiJoy Schmitz
Jun 30, 2005·Journal of Psychiatric Practice·Evaristo O Akerele, Frances R Levin
May 28, 2005·The Journal of Nervous and Mental Disease·Steven L SayersStanley N Caroff
Oct 8, 2020·Nature Reviews. Neuroscience·Marco VenniroYavin Shaham

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here